content: <PAGE>
  
  
                         SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549-1004
  
  
                                      FORM 8-K
                      CURRENT REPORT PURSUANT TO SECTION 13 OF
                         THE SECURITIES EXCHANGE ACT OF 1934
  
  
         Date of Report (date of earliest event reported): November 1, 2001
  
  
  
                                 CURON MEDICAL, INC.
               (Exact name of Registrant as specified in its charter)
  
  
  
              Delaware                    000-31519              77-0470324
  (State or other jurisdiction of     Commission File No.     (I.R.S. Employer
   incorporation or organization)                           Identification Number)
  
  
  
                                  735 Palomar Ave.
                             Sunnyvale, California 94085
                      (Address of principal executive offices)
  
                                   (408) 733-9910
                (Registrant's telephone number, including area code)
  
  
  <PAGE>
  
  ITEM 5. OTHER EVENTS
  
       On November 1, 2001, Curon Medical, Inc. issued a press release announcing
  that the Board of Directors of Curon Medical, Inc. approved the adoption of a
  Preferred Stock Rights Agreement. The press release is attached as Exhibit 99.1
  to this Form 8-K.
  
  ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
  
       (c) Exhibits.
  
           Exhibit 99.1     Curon Medical, Inc. Press Release issued November 1,
                            2001.
  
  
  <PAGE>
  
                                      SIGNATURE
  
       Pursuant to the requirements of the Securities Exchange Act or 1934, the
  registrant has duly caused this report to be signed on its behalf by the
  undersigned hereunto duly authorized.
  
                                              Curon Medical, Inc.
                                              (Registrant)
  
  Date:  November 9, 2001
                                              By:   /s/ John W. Morgan
                                                 -------------------------------
                                              John W. Morgan
                                              Chief Executive Officer
  
  
  
  
  <PAGE>
  
  
                                    EXHIBIT INDEX
  
  Exhibit
  Number
  -------
  
  99.1      Curon Medical, Inc. Press Release issued November 1, 2001.
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "d8k.txt", "description": "FORM 8-K", "secsgml_size_bytes": 2291}]
metadata_filer: {"company-data": {"conformed-name": "CURON MEDICAL INC", "cik": "0001114365", "assigned-sic": "3845", "irs-number": "770470324", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-31519", "film-number": "1780250"}, "business-address": {"street1": "735 PALOMAR AVENUE", "city": "SUNNYVALE", "state": "CA", "zip": "94086", "phone": "4087339910"}, "mail-address": {"street1": "735 PALOMAR AVENUE", "city": "SUNNYVALE", "state": "CA", "zip": "94086"}}
text: SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549-1004
  
                                      FORM 8-K
                      CURRENT REPORT PURSUANT TO SECTION 13 OF
                         THE SECURITIES EXCHANGE ACT OF 1934
  
         Date of Report (date of earliest event reported): November 1, 2001
  
                                 CURON MEDICAL, INC.
               (Exact name of Registrant as specified in its charter)
  
              Delaware                    000-31519              77-0470324
  (State or other jurisdiction of     Commission File No.     (I.R.S. Employer
   incorporation or organization)                           Identification Number)
  
                                  735 Palomar Ave.
                             Sunnyvale, California 94085
                      (Address of principal executive offices)
  
                                   (408) 733-9910
                (Registrant's telephone number, including area code)
  ITEM 5. OTHER EVENTS
  
       On November 1, 2001, Curon Medical, Inc. issued a press release announcing
  that the Board of Directors of Curon Medical, Inc. approved the adoption of a
  Preferred Stock Rights Agreement. The press release is attached as Exhibit 99.1
  to this Form 8-K.
  
  ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
  
       (c) Exhibits.
  
           Exhibit 99.1     Curon Medical, Inc. Press Release issued November 1,
                            2001.
  SIGNATURE
  
       Pursuant to the requirements of the Securities Exchange Act or 1934, the
  registrant has duly caused this report to be signed on its behalf by the
  undersigned hereunto duly authorized.
  
                                              Curon Medical, Inc.
                                              (Registrant)
  
  Date:  November 9, 2001
                                              By:   /s/ John W. Morgan
                                                 -------------------------------
                                              John W. Morgan
                                              Chief Executive Officer
  EXHIBIT INDEX
  
  Exhibit
  Number
  -------
  
  99.1      Curon Medical, Inc. Press Release issued November 1, 2001.